Dapagliflozin/metformin - AstraZeneca
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Licenced by Sun Pharmaceutical Industries
- Drug Class Antihyperglycaemics; Biguanides; Chlorobenzenes; Glucosides; Pyrans; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors; Glucose modulators; Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants ASTRAZENECA AB
- USA Patents 12
- NDAs 1
- International Patents 235
- Patent Applications 10
Table of Contents

Disclaimer